Year archive

Sharp Therapeutics Corp. — 2023 filings

All 11 regulatory filings released by Sharp Therapeutics Corp. (SHRX) in 2023, sourced directly from the official regulator.

11 Filings

2023 Period

2023 filings (11)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-08-16	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-08-16	English
Interim financial statements/report – English.pdf Regulatory Filings	2023-08-16	English
Interim MD&A - English.pdf Regulatory Filings	2023-08-16	English
Final prospectus – English.pdf Regulatory Filings	2023-05-11	English
Consent letter(s) of issuer's legal counsel.pdf Regulatory Filings	2023-05-11	English
Underwriting or agency agreement.pdf Regulatory Filings	2023-05-11	English
Escrow agreement.pdf Regulatory Filings	2023-05-11	English
Consent letter(s) of other legal counsel.pdf Regulatory Filings	2023-05-11	English
Auditors' consent letter.pdf Regulatory Filings	2023-05-10	English
Decision Document (Preliminary).PDF Regulatory Filings	2023-03-09	English